This invention relates to pharmaceutical compositions comprising
phenylcarbamoyl-methyl-indole derivatives that are found to be potent
modulators of potassium channels and, as such, are valuable candidates
for the treatment of diseases or disorders as diverse as those which are
responsive to the modulation of potassium channels.